Mawdsleys
Drug Stores & Pharmacies · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
S Langworthy Road Number Three, Salford,...Phone Number
+44 8447369016Website
www.mawdsleys.co.ukRevenue
$402.6 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
2
2
About Mawdsleys
Founded in 1825, Mawdsleys is a privately-owned pharmaceutical services company based in the UK with operations in international countries including Brazil. We deliver a wide range of services to both the pharmaceutical industry and healthcare sector through our main business areas which include: Named Patient Medicines (delivering global named patient programmes), Product Licensing and Market Access (In the EU, LATAM and Middle East regions), UK Wholesale (largest independent wholesaler to UK hospitals), UK Pre-wholesale (3PL and 4PL services in the UK), LUTO (healthcare communications) and Positive Solutions (pharmacy IT systems).Explore more
Mawdsleys Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mawdsleys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Mawdsleys has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Mawdsleys recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Mawdsleys
Funding: Get notified immidiatlly once Mawdsleys has new funding data
Mawdsleys, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Mawdsleys had a recent Job posting/layoffs
Check out if Mawdsleys is spiking on competitors!
Product Launch: Get notified when Mawdsleys launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Mawdsleys
Compare insights from companies similar to Mawdsleys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mawdsleys is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Mawdsleys is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Mawdsleys.
Mawdsleys Tech Stack
A closer look at the technologies used by Mawdsleys
See more technologies
Mawdsleys News & Media
Pharmaceutical distributor Mawdsleys unveils its expanded third-party logistics (3PL) warehouse in Doncaster - bigger and greener than before
Rt Hon Ed Miliband, Labour MP for Doncaster North and Shadow Secretary of State for Energy Security and Net Zero, officially opens Mawdsleys' expanded flagship facility today The Redhouse distribution hub, which has been doubled in size to 300,000 sq ft, is now almost the size of five...Mawdsleys and Meabco Launch a Named Patient Supply Program for BP-C1
LONDON--(BUSINESS WIRE)--Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer. BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride developed for patients suffering from metastatic breast cancer The Named Patient Supply program for the EU will allow physiciansMawdsleys and Oncoscience launch a Named Patient Program for CIMAher® (Nimotuzumab) in the UK and Ireland
LONDON--(BUSINESS WIRE)--#Mawdsleys--Mawdsleys and Oncoscience GmbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer. Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of cancers. These approvals have been granted for the following indications: locally advanced or metastatic pancreatic ca
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mawdsleys
Sign Up For FreeTo access detailed company insights
Founded in 1825, Mawdsleys is a privately-owned pharmaceutical services company based in the UK with operations in international countries including Brazil. We deliver a wide range of services to both the pharmaceutical industry and healthcare sector through our main business areas which include: Named Patient Medicines (delivering global named pat... Read More
